Chest Pain News and Research

RSS

Catheter-based ablation procedure reduces risks of death, stroke in AFib patients

Using catheter-based ablation instead of medications alone reduces the risks of death and stroke in patients with the common form of heart arrhythmia known as atrial fibrillation, or AFib, new research from UC Davis physicians shows.

30 Jun 2018

FDA grants approval for new device to treat breathing difficulty caused by severe emphysema

The U.S. Food and Drug Administration today approved a new device, the Zephyr Endobronchial Valve (Zephyr Valve), intended to treat breathing difficulty associated with severe emphysema.

29 Jun 2018

Diagnosing Coronary Heart Disease Using AI

Currently, stress echocardiograms used to diagnose heart disease are only 80% accurate, meaning many patients are misdiagnosed or sent home. Ultromics have developed a tool that uses machine learning to gather data and improve the accuracy of heart disease diagnoses to over 90%.

22 Jun 2018

Study: Effects of atrial fibrillation can be reduced or reversed by losing weight

Australian research shows for the first time that obese people who are suffering from atrial fibrillation can reduce or reverse the effects of the condition by losing weight.

20 Jun 2018

Research explores role of autopsy in cardiovascular medicine

Autopsy is often an overlooked source of medical insight which may be hindering advances in cardiovascular medicine, according to new research published in a special issue of the American Heart Association's journal Circulation.

18 Jun 2018

On-site pathology testing benefits remote Australians and helps save millions

On-site pathology testing is allowing remote Australians to receive effective emergency medical treatment close to home, while saving millions according to researchers.

12 Jun 2018

High-sensitive troponin T detects more cardiac infarctions than conventional ones, shows study

Five percent more cardiac infarctions detected and 11 percent fewer patients suffering a relapse. That is the result of a study of more than 80,000 patients in which two cardiac damage markers were compared with each other.

8 Jun 2018

Synthetic cannabis use may increase risk of heart attack and stroke

The warning follows their treatment of a 25 year old prison inmate who had no family history of heart disease or traditional cardiovascular risk factors, and who was left with a permanent disability.

8 Jun 2018

Patients diagnosed with high-sensitivity troponin test have lower risk of future heart attack

The newer high-sensitivity troponin test discovers smaller amounts of heart-specific proteins, troponins, than the older troponin test and thus identifies more myocardial infarction patients than before.

5 Jun 2018

Genomic medicine may redefine cardiovascular care in future, shows study

A new scientific statement from the American Heart Association summarizes the state-of-the-science of genomic medicine -- the study of the health effects of the molecular interactions of a person's unique genes -- for studying cardiovascular traits and disorders and for therapeutic screening.

29 May 2018

PCI along with prescribed drugs better than medication alone for treating for people with heart disease

A non-surgical procedure, called percutaneous coronary intervention, along with prescribed medication, is better than medication alone as initial treatment for people who have the most common form of heart disease, suggests an analysis of an international clinical trial co-led by St. Michael's Hospital.

22 May 2018

Frequent saunas may have beneficial effects on vascular health

Taking frequent saunas may be linked to a lower risk of stroke, according to a study published in the May 2, 2018, online issue of Neurology, the medical journal of the American Academy of Neurology.

3 May 2018

Researchers evaluate predictive value of stress testing and cardiac biomarkers in older women

Mayo Clinic researchers, reporting results of the SMART study, have shown that abnormal results on a stress electrocardiogram are an independent predictor of cardiovascular events such as heart attack, heart failure, hospitalization for chest pain, and death in perimenopausal or menopausal women.

2 May 2018

New results reinforce COPAXONE 40 mg/mL as safe and effective for RMS patients

Teva Pharmaceutical Industries Ltd., today announced up to 7-year efficacy, safety and tolerability results from the Glatiramer Acetate Low-Frequency Administration (GALA) open-label extension study of COPAXONE (glatiramer acetate injection) 40 mg/mL administered subcutaneously three-times-a-week for the treatment of relapsing forms of multiple sclerosis (RMS).

28 Apr 2018

Using biomimicry for faster detection of disease outbreaks

Our immune systems are made up of billions of white blood cells searching for signs of infections and foreign invaders, ready to raise the alarm.

9 Apr 2018

Study reveals reduced risk of dementia for physically fit women

Middle aged women with high physical fitness are 90% less likely to develop dementia in the future, according to a recent study.

15 Mar 2018

Women with high physical fitness at middle age 90% less likely to develop dementia

Women with high physical fitness at middle age were nearly 90 percent less likely to develop dementia decades later, compared to women who were moderately fit, according to a study published the March 14, 2018, online issue of Neurology, the medical journal of the American Academy of Neurology.

15 Mar 2018

The Importance of Fetal Fibronectin Testing for Women with Symptomatic Preterm Labor

Preterm birth is a dangerous condition that often goes undiagnosed. Fetal fibronectin (fFN) is a biomarker for preterm labor, but testing for fFN is widely underused. We explore this issue with Dr. Michael S. Ruma, a maternal-fetal specialist from the Perinatal Associates of New Mexico.

14 Mar 2018

Patients given six-month dual antiplatelet therapy have increased heart attack risk

The combined rate of death from any cause, heart attack or stroke within 18 months was not significantly different in patients with acute coronary syndrome who were randomly assigned to receive dual antiplatelet therapy for either six months or at least 12 months after receiving a drug-eluting stent.

13 Mar 2018

Statins may provide benefits to patients who underwent percutaneous coronary intervention

Getting a large dose of a statin did not have an impact on major adverse cardiac events among a broad population of patients slated to undergo percutaneous coronary intervention, a procedure to clear blocked arteries, in a trial being presented at the American College of Cardiology's 67th Annual Scientific Session.

12 Mar 2018